Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
23847studies shown
Showing 3,181-3,192 of 23,847
Drug study icon
RecruitingNCT05450432

Long-Term Maintenance With Ketamine and Esketamine for Reduction of Suicide in High-Risk people with Depression

This observational study is following people with depression to understand outcomes over time. Participants mainly provide questionnaire, assessment, or follow-up information rather than receiving a new study treatment.

In Boston
DepressionDrugA study involving a medication or substance.From 18 Years to 70 Years
Countries
United States
Sponsor
Massachusetts General Hospital
Condition
Depression
Other study type icon
RecruitingNCT04877977

Long-term Observation of people with Mood Disorders

This study is recruiting in the United States. It focuses on Suicide prevention.

In Bethesda
Suicidality, DepressionOtherFrom 18 Years to 99 Years
Countries
United States
Sponsor
National Institute of Mental Health (NIMH)
Condition
Suicidality, Depression
Drug study icon
RecruitingNCT06966401

NBI-1065845 for depression

This study is recruiting in the United States, in the United Kingdom, in Belgium, .... It is testing NBI-1065845 for depression.

Multiple locations, including Huntsville
DepressionDrugOver 18 Years
Countries
United States, United Kingdom, Belgium, ...
Sponsor
Neurocrine Biosciences
Condition
Depression
Behavioral study icon
RecruitingNCT05534815

Long-Term Treatment of Addiction

This summary needs review. Please check the official study record and contact the research team for details.

In Marquette
AddictionBehavioralOver 18 Years
Countries
United States
Sponsor
Northern Michigan University
Condition
Addiction
Other study type icon
RecruitingNCT06207162

Longitudinal Neural Fingerprinting of Opioid-use Trajectories

This summary needs review. Please check the official study record and contact the research team for details.

In New Haven
AddictionDiagnostic TestA study that looks at how to detect, measure, or better understand a condition.From 18 Years to 50 Years
Countries
United States
Sponsor
Yale University
Condition
Addiction
Drug study icon
RecruitingNCT06107062

Longitudinal Outpatient Treatment for Addiction

This summary needs review. Please check the official study record and contact the research team for details.

In Boulder
AddictionDrugOver 21 Years
Countries
United States
Sponsor
University of Colorado, Boulder
Condition
Addiction
Drug study icon
RecruitingNCT06636812

Losartan and Emotional Processing in Young People

This summary needs review. Please check the official study record and contact the research team for details.

In Oxford
AnxietyDrugFrom 16 Years to 20 Years
Countries
United Kingdom
Sponsor
University of Oxford
Condition
Anxiety
Behavioral study icon
RecruitingNCT06529029

Low Amplitude Pulse Seizure Therapy Versus Standard Ultra-Brief Right Unilateral Electroconvulsive Therapy

This study is looking at whether Sigma-Stim can help people with Suicide prevention, depression, Schizo Affective Disorder, or bipolarity. Participants take part in Sigma-Stim and complete follow-up assessments.

In Grand Rapids
Depression, Suicidality, ...BehavioralFrom 18 Years to 90 Years
Countries
United States
Sponsor
Michigan State University
Condition
Depression, Suicidality, ...
Device study icon
RecruitingNCT06986460

Low Frequency Right Dorsolateral Pre Frontal Cortical Repetitive TMS for Depression in bipolarity

This observational study is following people with Depression in bipolarity Depressed Phase to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.

In Toronto
Bipolarity, DepressionDeviceA study involving a tool, app, wearable, test, or medical device.Over 18 Years
Countries
Canada
Sponsor
Tyler Kaster
Condition
Bipolarity, Depression
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.